Ketone supplement shows promise for brain fog in early memory loss
NCT ID NCT06962501
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested whether a single dose of an oral ketone supplement could increase blood flow and improve brain connectivity in 15 older adults with subjective or mild cognitive decline. Participants had one 2-hour session including MRI scans and cognitive tests. The goal is to see if this supplement might help support brain health in early memory problems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
oral ketone monoester supplement
What this could lead to
If it works, this could point toward a simple dietary supplement that temporarily improves brain function in people with early memory problems.
What could go wrong
This is a very small, early pilot study with only 15 participants and a single dose. Results may not apply to long-term use or to the general population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBJECTIVE COGNITIVE DECLINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Basel
Basel, Canton of Basel-City, 4031, Switzerland